Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Welch

Showing results (721-730 of 797) with videos related to

Pageof 80
Sort By:
Neoplasia (New York, N.Y.)|April 27, 2007
Claudin-4 overexpression in epithelial ovarian cancer is associated with hypomethylation and is a potential target for modulation of tight junction barrier function using a C-terminal fragment of Clostridium perfringens enterotoxinBabak Litkouhi, Joseph Kwong, Chun-Min Lo, et al.
The Journal of Infectious Diseases|January 31, 2022
Lassa Virus Replicon Particle Vaccine Protects Strain 13/N Guinea Pigs Against Challenge With Geographically and Genetically Diverse Viral StrainsJessica R Spengler, Markus H Kainulainen, Stephen R Welch, et al.
Cancer Research|December 20, 2013
Metastasis suppressor KISS1 seems to reverse the Warburg effect by enhancing mitochondrial biogenesisWen Liu, Benjamin H Beck, Kedar S Vaidya, et al.
Antiviral Research|March 1, 2024
Third International Conference on Crimean-Congo Hemorrhagic Fever in Thessaloniki, Greece, September 19-21, 2023Stephen R Welch, Aura R Garrison, Dennis A Bente, et al.
Antiviral Research|December 3, 2024
Crimean-Congo hemorrhagic fever virus replicon particle vaccine is safe and elicits functional, non-neutralizing anti-nucleoprotein antibodies and T cell activation in rhesus macaquesAlyssa Kleymann, Elif Karaaslan, Florine E M Scholte, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 15, 2006
Kinetics of metastatic breast cancer cell trafficking in bonePushkar A Phadke, Robyn R Mercer, John F Harms, et al.
Nature Methods|June 19, 2023
Multiplex-GAM: genome-wide identification of chromatin contacts yields insights overlooked by Hi-CRobert A Beagrie, Christoph J Thieme, Carlo Annunziatella, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|November 24, 2020
The impact of pre-eclampsia definitions on the identification of adverse outcome risk in hypertensive pregnancy - analyses from the CHIPS trial (Control of Hypertension in Pregnancy Study)L A Magee, J Singer, T Lee, et al.
EMBO Molecular Medicine|June 19, 2012
Casein kinase I epsilon interacts with mitochondrial proteins for the growth and survival of human ovarian cancer cellsNoah Rodriguez, Junzheng Yang, Kathleen Hasselblatt, et al.
NPJ Vaccines|November 21, 2025
Durable humoral immunity and long-term protection induced by a Crimean-Congo hemorrhagic fever virus replicon particle vaccine in miceTeresa E Sorvillo, Elif Karaaslan, Katherine A Davies, et al.
Pageof 80

Showing results (721-730 of 797) with videos related to

Sort By:
Pageof 80
Neoplasia (New York, N.Y.)|April 27, 2007
Claudin-4 overexpression in epithelial ovarian cancer is associated with hypomethylation and is a potential target for modulation of tight junction barrier function using a C-terminal fragment of Clostridium perfringens enterotoxinBabak Litkouhi, Joseph Kwong, Chun-Min Lo, et al.
The Journal of Infectious Diseases|January 31, 2022
Lassa Virus Replicon Particle Vaccine Protects Strain 13/N Guinea Pigs Against Challenge With Geographically and Genetically Diverse Viral StrainsJessica R Spengler, Markus H Kainulainen, Stephen R Welch, et al.
Cancer Research|December 20, 2013
Metastasis suppressor KISS1 seems to reverse the Warburg effect by enhancing mitochondrial biogenesisWen Liu, Benjamin H Beck, Kedar S Vaidya, et al.
Antiviral Research|March 1, 2024
Third International Conference on Crimean-Congo Hemorrhagic Fever in Thessaloniki, Greece, September 19-21, 2023Stephen R Welch, Aura R Garrison, Dennis A Bente, et al.
Antiviral Research|December 3, 2024
Crimean-Congo hemorrhagic fever virus replicon particle vaccine is safe and elicits functional, non-neutralizing anti-nucleoprotein antibodies and T cell activation in rhesus macaquesAlyssa Kleymann, Elif Karaaslan, Florine E M Scholte, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 15, 2006
Kinetics of metastatic breast cancer cell trafficking in bonePushkar A Phadke, Robyn R Mercer, John F Harms, et al.
Nature Methods|June 19, 2023
Multiplex-GAM: genome-wide identification of chromatin contacts yields insights overlooked by Hi-CRobert A Beagrie, Christoph J Thieme, Carlo Annunziatella, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|November 24, 2020
The impact of pre-eclampsia definitions on the identification of adverse outcome risk in hypertensive pregnancy - analyses from the CHIPS trial (Control of Hypertension in Pregnancy Study)L A Magee, J Singer, T Lee, et al.
EMBO Molecular Medicine|June 19, 2012
Casein kinase I epsilon interacts with mitochondrial proteins for the growth and survival of human ovarian cancer cellsNoah Rodriguez, Junzheng Yang, Kathleen Hasselblatt, et al.
NPJ Vaccines|November 21, 2025
Durable humoral immunity and long-term protection induced by a Crimean-Congo hemorrhagic fever virus replicon particle vaccine in miceTeresa E Sorvillo, Elif Karaaslan, Katherine A Davies, et al.
Pageof 80